Guardian Pharmacy Services, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
GRDN$47.02+10.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (In thousands, except share amounts) | December 31,2025 | September 30,2026 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $65,619 | $119,655 |
| Accounts receivable, net | 101,614 | 107,677 |
| Inventories | 43,359 | 57,051 |
| Other current assets | 11,042 | 10,434 |
| Total current assets | 221,634 | 294,817 |
| Property and equipment, net | 55,522 | 57,424 |
| Intangible assets, net | 18,475 | 20,842 |
| Goodwill | 79,743 | 81,954 |
| Operating lease right-of-use assets | 34,649 | 32,774 |
| Deferred tax assets | 2,199 | 2,618 |
| Other assets | 436 | 1,347 |
| Total assets | $412,658 | $491,776 |
| Liabilities and equity | ||
| Current liabilities: | ||
| Accounts payable | $116,206 | $126,307 |
| Accrued compensation | 15,048 | 19,874 |
| Operating leases, current portion | 7,150 | 7,632 |
| Other current liabilities | 22,299 | 25,276 |
| Total current liabilities | 160,703 | 179,089 |
| Operating leases, net of current portion | 29,992 | 27,962 |
| Other liabilities | 4,039 | 5,005 |
| Total liabilities | $194,734 | $212,056 |
| Commitments and contingencies (see Note 6) | ||
| Equity: | ||
| Class A common stock - 700,000,000 shares authorized, par value $0.001; 36,253,744 and 63,320,300 shares issued and outstanding as of December 31, 2025 and September 30, 2026, respectively | 36 | 63 |
| Class B common stock - 100,000,000 shares authorized, par value $0.001; 27,066,890 and 22,004 shares issued and outstanding as of December 31, 2025 and September 30, 2026, respectively | 27 | — |
| Additional paid-in capital | 139,353 | 146,982 |
| Retained earnings | 66,343 | 120,190 |
| Non-controlling interests | 12,165 | 12,485 |
| Total equity | 217,924 | 279,720 |
| Total liabilities and equity | $412,658 | $491,776 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.